ChartMill is a comprehensive online stock research platform designed to empower traders and investors with advanced tools for technical and fundamental analysis. The company provides a robust stock screener that allows users to filter thousands of stocks across major exchanges like NYSE, NASDAQ, and EURONEXT, using over 180 customizable technical and fundamental parameters to identify trading opportunities.
As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Alphatec Holdings (ATEC) smashed Q3 2025 earnings estimates, beating on revenue and swinging to a profit. The stock surged over 21% as the company also raised its full-year 2025 guidance.
TFS Financial (TFSL) reported record annual earnings for fiscal 2025, with Q4 EPS beating estimates. The company saw strong growth in net interest income and retail deposits.
Ardelyx (ARDX) stock surged 15% after Q3 2025 results, beating revenue estimates with strong growth from its drug IBSRELA and raising its full-year guidance.
Gilead Sciences Q3 2025 earnings beat EPS estimates with $2.47, but revenue outlook is cautious. HIV drug Biktarvy drives growth, while Veklury sales decline.
Lumen Technologies (LUMN) reported mixed Q3 results, beating earnings estimates with a smaller-than-expected loss despite a slight revenue decline. The stock rose on the news.
COPT Defense Properties (CDP) Q3 2025 earnings crush estimates, with FFO of $0.69 vs. $0.35 forecast. The company also raises its full-year 2025 guidance.
Axos Financial's Q1 2026 earnings beat estimates, but revenue fell short. The digital bank showed strong loan and deposit growth, including the Verdant acquisition.
Rimini Street posts mixed Q3 results, returning to GAAP profitability but missing revenue estimates. The stock showed little movement as investors await future guidance.
Monolithic Power Systems (MPWR) beat Q3 2025 earnings and revenue estimates, offering strong Q4 guidance. Despite the positive results, the stock fell over 6% in after-hours trading.
Alignment Healthcare (ALHC) beat Q3 2025 earnings and revenue estimates, posting a surprise profit. The company also raised its full-year outlook, driving positive market reaction.
ICF International (ICFI) missed Q3 2025 earnings and revenue estimates. Despite the miss, the company highlighted strong growth in its commercial and international government segments.
Arrow Electronics posted Q3 earnings of $2.41 per share, beating estimates. Revenue of $7.71B slightly missed forecasts. The company issued cautious Q4 guidance.
Atlassian stock surged after a strong Q1 FY26 earnings beat. The company surpassed EPS estimates and reported 21% revenue growth, driven by cloud and AI adoption.
Weyerhaeuser's Q3 2025 earnings beat EPS estimates but missed on revenue. The timber giant reported a profit of $0.06 per share versus a projected loss.
VICI Properties Q3 2025 results show steady revenue growth but a miss on AFFO per share. The REIT also announced a new lease and updated its 2025 guidance.
Ingersoll Rand's Q3 earnings met EPS estimates but revenue slightly missed. The company revised its full-year 2025 guidance lower, causing a cautious market response.
National CineMedia (NCMI) reported mixed Q3 2025 earnings, with revenue missing estimates but profitability improving. The company also provided strong Q4 revenue guidance.
Stryker's Q3 2025 results were mixed: EPS beat estimates but revenue slightly missed. Shares fell as the market digested the strong earnings against the updated full-year guidance.
OneSpan's Q3 2025 results show a mixed performance with an EPS beat but a revenue miss. The stock fell sharply due to lowered full-year revenue and ARR guidance.
Floor & Decor (FND) Q3 earnings beat EPS estimates by 15.6%, with strong profit growth despite a slight revenue miss. The stock surged on the positive results.
SPX Technologies Q3 2025 results beat revenue and earnings estimates. The company also raised its full-year revenue guidance, signaling strong performance.
Digimarc's Q3 2025 results show a revenue miss but a significantly improved bottom line. The stock fell 7% despite aggressive cost-cutting and strategic progress in authentication tech.
Resmed's Q1 FY2026 earnings met expectations with $1.34B revenue and $2.55 EPS. Despite strong profit growth and margin expansion, the stock traded lower post-announcement.
Strategy Inc (MSTR) beat Q3 2025 earnings estimates, returning to profitability driven by its massive bitcoin holdings and a $3.9 billion unrealized gain.
RGA's Q3 2025 earnings beat estimates with record results, driven by strong performance in its global business segments and strategic capital deployment.
Alkami Technology's Q3 2025 results were mixed, missing revenue estimates but beating on EPS. The stock fell after hours as investors reacted to the sales shortfall.
Columbia Banking System (COLB) beat Q3 2025 earnings and revenue estimates, with EPS of $0.85 vs. $0.70 expected. The strong results drove a positive stock reaction.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Thursday and uncover the stocks that are leading the way in terms of trading volume and market attention.
Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Discover how TransMedics Group (TMDX) exemplifies a powerful growth investing strategy with explosive sales, earnings growth, and soaring profitability.
Medical Properties Trust (MPW) Q3 2025 earnings beat analyst estimates with strong NFFO of $0.13 per share. Revenue also exceeded forecasts amid ongoing portfolio restructuring.
